LHC Group, Inc. (NASDAQ:LHCG) has been given an average rating of “Buy” by the fifteen analysts that are covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $121.30.
A number of analysts recently issued reports on LHCG shares. Zacks Investment Research upgraded shares of LHC Group from a “sell” rating to a “hold” rating in a research report on Saturday, May 11th. BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 28th. UBS Group set a $133.00 target price on shares of LHC Group and gave the stock a “buy” rating in a research report on Friday, May 10th. Barclays raised their target price on shares of LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 21st. Finally, Craig Hallum raised their target price on shares of LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a research report on Friday, March 1st. They noted that the move was a valuation call.
In other news, CEO Keith G. Myers sold 75,000 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $108.53, for a total value of $8,139,750.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Donald Dwayne Stelly sold 15,151 shares of the firm’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $107.06, for a total transaction of $1,622,066.06. Following the completion of the transaction, the chief operating officer now directly owns 92,065 shares in the company, valued at approximately $9,856,478.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 117,876 shares of company stock worth $12,762,540. 5.20% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the company. Parallel Advisors LLC increased its stake in LHC Group by 790.0% during the 1st quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after buying an additional 237 shares during the period. Sageworth Trust Co purchased a new stake in LHC Group during the 1st quarter worth $36,000. Financial Gravity Companies Inc. purchased a new stake in LHC Group during the 4th quarter worth $49,000. Quadrant Capital Group LLC increased its stake in LHC Group by 1,045.7% during the 1st quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after buying an additional 481 shares during the period. Finally, Meeder Asset Management Inc. purchased a new stake in LHC Group during the 1st quarter worth $68,000. 94.07% of the stock is currently owned by institutional investors and hedge funds.
Shares of LHCG traded up $2.30 during mid-day trading on Thursday, reaching $119.55. 7,784 shares of the company’s stock were exchanged, compared to its average volume of 259,886. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57. LHC Group has a 52-week low of $73.09 and a 52-week high of $117.70. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of 33.68, a price-to-earnings-growth ratio of 1.94 and a beta of 0.87.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, May 8th. The health services provider reported $0.98 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The business had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. On average, equities analysts expect that LHC Group will post 4.3 earnings per share for the current fiscal year.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.